Kasvajavastased ained, immunosupressandid, oftalmoloogias kasutatavad ained, hingamisteede obstruktiivsete haiguste raviks kasutatavad ained, migreenivastased ained
Contracts total
93 900 000 €
Bids
3
Type
Supplies
Published
07.11.2024
Tender description
Kasvajavastaste ainete, immunosupressantide, oftalmoloogias kasutatavate ainete, hingamisteede obstruktiivsete haiguste raviks kasutatavate ainete, migreenivastaste ainete ostmine
Awarded contracts
04.02.2025| Lot | Tenderer | Amount | Bids | Awarded |
|---|---|---|---|---|
| Panitumumab | TAMRO EESTI OÜ | 200 000 € | 2 | 22.01.2025 |
| Brentuksimabvedotiin | TAMRO EESTI OÜ | 1 500 000 € | 1 | 14.01.2025 |
| Pertuzumab | Roche Eesti Osaühing | 2 500 000 € | 1 | 14.01.2025 |
| Trastuzumabemtansiin | Roche Eesti Osaühing | 6 000 000 € | 1 | 14.01.2025 |
| Obinutuzumab | Roche Eesti Osaühing | 1 500 000 € | 1 | 14.01.2025 |
| Nivolumab | TAMRO EESTI OÜ | 10 000 000 € | 1 | 14.01.2025 |
| Pembrolizumab | MAGNUM MEDICAL OÜ | 18 000 000 € | 1 | 13.01.2025 |
| Blinatumomab | TAMRO EESTI OÜ | 1 000 000 € | 2 | 22.01.2025 |
| Daratumumab | TAMRO EESTI OÜ | 18 000 000 € | 2 | 22.01.2025 |
| Inotuzumabosogamitsiin | TAMRO EESTI OÜ | 500 000 € | 1 | 14.01.2025 |
| Durvalumab | MAGNUM MEDICAL OÜ | 3 000 000 € | 1 | 13.01.2025 |
| Atezolisumab | Roche Eesti Osaühing | 6 000 000 € | 1 | 14.01.2025 |
| Ipilimumab | TAMRO EESTI OÜ | 3 000 000 € | 1 | 14.01.2025 |
| Karfilsomiib | TAMRO EESTI OÜ | 1 000 000 € | 2 | 22.01.2025 |
| Iksasomiib | MAGNUM MEDICAL OÜ | 500 000 € | 1 | 13.01.2025 |
| Pertuzumab + trastuzumab | Roche Eesti Osaühing | 6 000 000 € | 1 | 14.01.2025 |
| Küüliku anti-T-lümfotsüütne immuunoglobuliin | MAGNUM MEDICAL OÜ | 200 000 € | 1 | 13.01.2025 |
| Okrelizumab | Roche Eesti Osaühing | 1 000 000 € | 1 | 14.01.2025 |
| Vedolizumab | TAMRO EESTI OÜ | 1 500 000 € | 1 | 14.01.2025 |
| Golimumab | TAMRO EESTI OÜ | 1 000 000 € | 2 | 22.01.2025 |
| Anakinra | TAMRO EESTI OÜ | 200 000 € | 2 | 22.01.2025 |
| Ustekinumab | TAMRO EESTI OÜ | 1 000 000 € | 3 | 22.01.2025 |
| Sarilumab | MAGNUM MEDICAL OÜ | 1 000 000 € | 1 | 13.01.2025 |
| Polatuzumabvedotiin | Roche Eesti Osaühing | 3 000 000 € | 1 | 14.01.2025 |
| Omalizumab | MAGNUM MEDICAL OÜ | 1 500 000 € | 2 | 23.01.2025 |
| Mepolizumab | TAMRO EESTI OÜ | 1 500 000 € | 2 | 22.01.2025 |
| Benralizumab | MAGNUM MEDICAL OÜ | 1 500 000 € | 1 | 13.01.2025 |
| Tesepelumab | MAGNUM MEDICAL OÜ | 1 000 000 € | 1 | 13.01.2025 |
| Eptinezumab | MAGNUM MEDICAL OÜ | 500 000 € | 1 | 13.01.2025 |
| Faritsimab | Roche Eesti Osaühing | 300 000 € | 1 | 14.01.2025 |
Tender lots
32| Lot | Estimated value | Deadline |
|---|---|---|
| Panitumumab | 53 040 € | 11.12.2024 |
| Gemtuzumabosogamtsiin | 27 035 € | 11.12.2024 |
| Brentuksimabvedotiin | 408 900 € | 11.12.2024 |
| Pertuzumab | 883 840 € | 11.12.2024 |
| Trastuzumabemtansiin | 2 418 000 € | 11.12.2024 |
| Obinutuzumab | 433 200 € | 11.12.2024 |
| Nivolumab | 3 812 800 € | 11.12.2024 |
| Pembrolizumab | 7 547 400 € | 11.12.2024 |
| Blinatumomab | 39 420 € | 11.12.2024 |
| Daratumumab | 8 366 400 € | 11.12.2024 |
| Inotuzumabosogamitsiin | 62 600 € | 11.12.2024 |
| Durvalumab | 1 115 100 € | 11.12.2024 |
| Atezolisumab | 2 871 000 € | 11.12.2024 |
| Ipilimumab | 1 294 650 € | 11.12.2024 |
| Karfilsomiib | 299 000 € | 11.12.2024 |
| Iksasomiib | 140 200 € | 11.12.2024 |
| Pertuzumab + trastuzumab | 1 893 000 € | 11.12.2024 |
| Küüliku anti-T-lümfotsüütne immuunoglobuliin | 17 500 € | 11.12.2024 |
| Okrelizumab | 228 120 € | 11.12.2024 |
| Vedolizumab | 366 000 € | 11.12.2024 |
| Golimumab | 368 550 € | 11.12.2024 |
| Anakinra | 30 400 € | 11.12.2024 |
| Ustekinumab | 202 000 € | 11.12.2024 |
| Sarilumab | 157 600 € | 11.12.2024 |
| Belimumab | 11 664 € | 11.12.2024 |
| Polatuzumabvedotiin | 1 085 000 € | 11.12.2024 |
| Omalizumab | 336 600 € | 11.12.2024 |
| Mepolizumab | 440 220 € | 11.12.2024 |
| Benralizumab | 386 750 € | 11.12.2024 |
| Tesepelumab | 194 000 € | 11.12.2024 |
| Eptinezumab | 108 900 € | 11.12.2024 |
| Faritsimab | 78 400 € | 11.12.2024 |
Similar open tenders
- Parenteraalsed toitelahusedOpen for bidsDeadline 20.10.2026 2 daysEstimated value 400 000 €Published 18.09.2026
- KlesrovimabOpen for bidsDeadline 20.10.2026 2 daysEstimated value 190 000 €Published 05.10.2026
- Puhasruumide desinfektsiooni- ja puhastusvahendidOpen for bidsDeadline 21.10.2026 3 daysPublished 17.09.2026
- Urogenitaalsüsteemi ravimid ja hormoonravimidOpen for bidsDeadline 23.10.2026 5 daysPublished 18.09.2026
- Ravim B01AB05 EnoksapariinOpen for bidsDeadline 27.10.2026 9 daysPublished 21.09.2026
- Kemoteraapias kasutatavad ravimidOpen for bidsDeadline 27.10.2026 9 daysPublished 22.09.2026
Source: Public Procurement Register open data. Amounts exclude VAT. The notice published in the Public Procurement Register is binding.